Latest Insider Transactions at Galectin Therapeutics Inc (GALT)
This section provides a real-time view of insider transactions for Galectin Therapeutics Inc (GALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GALECTIN THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GALECTIN THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2024
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$1,000
$2.6 P/Share
|
|
Oct 17
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
1,300
+3.6%
|
$2,600
$2.64 P/Share
|
|
Oct 16
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+5.88%
|
$10,000
$2.7 P/Share
|
|
Oct 16
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
5,000
+13.0%
|
$10,000
$2.7 P/Share
|
|
Aug 23
2024
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
1,759
+5.2%
|
$3,518
$2.3 P/Share
|
|
Aug 23
2024
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Indirect |
1,000
+33.33%
|
$2,000
$2.3 P/Share
|
|
Aug 22
2024
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
741
+2.39%
|
$1,482
$2.3 P/Share
|
|
Jun 20
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
2,500
+8.07%
|
$5,000
$2.38 P/Share
|
|
Apr 30
2024
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$3,000
$3.52 P/Share
|
|
Apr 24
2024
|
Joel Lewis President and CEO |
BUY
Open market or private purchase
|
Indirect |
1,000
+33.33%
|
$3,000
$3.39 P/Share
|
|
Apr 23
2024
|
James C Czirr > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,677
-0.06%
|
$11,031
$3.06 P/Share
|
|
Apr 22
2024
|
James C Czirr > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,323
-0.36%
|
$63,969
$3.06 P/Share
|
|
Apr 22
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
2,500
+8.78%
|
$5,000
$2.98 P/Share
|
|
Apr 09
2024
|
Kevin D Freeman |
BUY
Acquisition or disposition by will or laws
|
Indirect |
2,063
+10.25%
|
-
|
|
Mar 01
2024
|
Joel Lewis President and CEO |
SELL
Grant, award, or other acquisition
|
Direct |
152,584
-14.53%
|
$152,584
$1.96 P/Share
|
|
Jan 24
2024
|
Richard E Uihlein |
BUY
Grant, award, or other acquisition
|
Direct |
23,256
+0.23%
|
$23,256
$1.72 P/Share
|
|
Jan 16
2024
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
900
+0.9%
|
$1,800
$2.09 P/Share
|
|
Dec 29
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,606
+1.1%
|
$11,606
$1.66 P/Share
|
|
Dec 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,042
+1.15%
|
$12,042
$1.6 P/Share
|
|
Nov 30
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,880
+0.96%
|
$9,880
$1.95 P/Share
|
|
Nov 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,303
+1.01%
|
$10,303
$1.87 P/Share
|
|
Oct 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,444
+0.94%
|
$18,888
$2.04 P/Share
|
|
Oct 13
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,035
+1.0%
|
$20,070
$2.01 P/Share
|
|
Sep 29
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,035
+1.01%
|
$10,035
$1.92 P/Share
|
|
Sep 26
2023
|
Richard E Uihlein |
BUY
Exercise of conversion of derivative security
|
Direct |
2,236,204
+4.2%
|
$6,708,612
$3.85 P/Share
|
|
Sep 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,947
+1.12%
|
$10,947
$1.76 P/Share
|
|
Aug 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,010
+1.14%
|
$11,010
$1.75 P/Share
|
|
Aug 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,042
+1.26%
|
$12,042
$1.6 P/Share
|
|
Jul 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,844
+1.35%
|
$12,844
$1.5 P/Share
|
|
Jul 19
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,598
+3.17%
|
$1,598
$1.79 P/Share
|
|
Jul 14
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,820
+1.27%
|
$11,820
$1.63 P/Share
|
|
Jun 30
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,380
+93.63%
|
$13,380
$1.44 P/Share
|
|
Jun 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,196
+1.45%
|
$13,196
$1.46 P/Share
|
|
May 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,272
+1.37%
|
$12,272
$1.57 P/Share
|
|
May 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,748
+1.33%
|
$11,748
$1.64 P/Share
|
|
Apr 28
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,947
+1.26%
|
$10,947
$1.76 P/Share
|
|
Apr 14
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,585
+1.12%
|
$19,170
$2.01 P/Share
|
|
Mar 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,175
+1.08%
|
$18,350
$2.1 P/Share
|
|
Mar 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,140
+1.21%
|
$10,140
$1.9 P/Share
|
|
Mar 01
2023
|
Joel Lewis President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
75,529
-8.43%
|
$151,058
$2.07 P/Share
|
|
Feb 28
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,308
+1.03%
|
$18,616
$2.07 P/Share
|
|
Feb 21
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,000
+2.07%
|
$1,000
$1.59 P/Share
|
|
Feb 16
2023
|
Joel Lewis President and CEO |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$1,000
$1.52 P/Share
|
|
Feb 15
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,380
+1.49%
|
$13,380
$1.44 P/Share
|
|
Feb 07
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
143,836
+14.14%
|
$143,836
$1.43 P/Share
|
|
Jan 31
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,086
+2.03%
|
$15,086
$1.16 P/Share
|
|
Jan 26
2023
|
Richard E Uihlein |
BUY
Grant, award, or other acquisition
|
Direct |
36,036
+0.45%
|
$36,036
$1.11 P/Share
|
|
Jan 25
2023
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,300
+2.74%
|
$1,300
$1.11 P/Share
|
|
Jan 13
2023
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,351
+2.1%
|
$15,351
$1.14 P/Share
|
|
Dec 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,487
+2.17%
|
$15,487
$1.13 P/Share
|